Drug intelligence / Profile preview

beta-(2-naphthyl)-alanine

Development stage
Unknown
Modality
Small Molecules
01

Overview

Beta-(2-Naphthyl)-Alanine is a synthetic, non-proteinogenic amino acid derivative characterized by the presence of a naphthalene ring attached to the β-carbon of alanine. It exists in both L and D enantiomeric forms. The compound is primarily used as a building block in peptide synthesis, where its bulky aromatic side chain can modulate peptide structure and function. In research settings, it has been studied for its ability to inhibit peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), as well as prothrombin, suggesting potential utility in modulating protein folding and coagulation pathways[1][8]. Its hydrophobicity and steric properties make it valuable for designing peptides with enhanced stability or altered biological activity. Beta-(2-Naphthyl)-Alanine has also been explored as a fluorescent probe in receptor studies due to its aromatic moiety[8].

Other names
2-naphthylalaninebeta-naphthylalanine(S)-2-amino-3-(naphthalen-2-yl)propanoic acid(R)-2-amino-3-(naphthalen-2-yl)propanoic acidL-beta-(2-naphthyl)alanineD-beta-(2-naphthyl)alanine
02

Targets

PIN1 (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1)F2 (Thrombin)

Beyond the preview

Go deeper on beta-(2-naphthyl)-alanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-(2-naphthyl)-alanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call